Norihiro Nakada

534 total citations
20 papers, 407 citations indexed

About

Norihiro Nakada is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Norihiro Nakada has authored 20 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Norihiro Nakada's work include Amino Acid Enzymes and Metabolism (6 papers), Epigenetics and DNA Methylation (4 papers) and Polyamine Metabolism and Applications (3 papers). Norihiro Nakada is often cited by papers focused on Amino Acid Enzymes and Metabolism (6 papers), Epigenetics and DNA Methylation (4 papers) and Polyamine Metabolism and Applications (3 papers). Norihiro Nakada collaborates with scholars based in Japan, Taiwan and Singapore. Norihiro Nakada's co-authors include Isao Okayasu, Masaaki Ichinoe, Hitoshi Endou, Tetuo Mikami, Nobuyuki Yanagisawa, Kiyomi Hana, Tsutomu Yoshida, Yoshiki Murakumo, Tomoko Tsuruta and Wasaburo Koizumi and has published in prestigious journals such as Cancer Letters, Journal of Clinical Pathology and Human Pathology.

In The Last Decade

Norihiro Nakada

19 papers receiving 401 citations

Peers

Countries citing papers authored by Norihiro Nakada

Since Specialization

Citations

This map shows the geographic impact of Norihiro Nakada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiro Nakada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiro Nakada more than expected).

Fields of papers citing papers by Norihiro Nakada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihiro Nakada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiro Nakada. The network helps show where Norihiro Nakada may publish in the future.

Co-authorship network of co-authors of Norihiro Nakada

This figure shows the co-authorship network connecting the top 25 collaborators of Norihiro Nakada. A scholar is included among the top collaborators of Norihiro Nakada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihiro Nakada. Norihiro Nakada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms 2024 ·Pathology International ·Masafumi Seki, Akira Satou, (unknown), Tomoko Tamaki, Naoki Wada, Norihiro Nakada, Hirofumi Matsumoto, (unknown), (unknown), (unknown), Toyonori Tsuzuki, Kennosuke Karube	1
2	Ki‐67 evaluation using deep‐learning model‐assisted digital image analysis in breast cancer 2024 ·Histopathology ·Hirofumi Matsumoto, (unknown), (unknown), Norihiro Nakada, (unknown), (unknown), (unknown), Hisamitsu Zaha	1
3	Unusual presentation of breast adenoid cystic carcinoma resembling adenomyoepithelioma with multiple distinct foci 2023 ·Pathology - Research and Practice ·Hirofumi Matsumoto, Hiroshi Harada, (unknown), (unknown), Norihiro Nakada, (unknown), (unknown), (unknown), (unknown), Hisamitsu Zaha, Puay Hoon Tan	1
4	Predictive value of ductal carcinoma in situ with invasive breast cancer in core needle biopsies for final pathologic size of intraductal elements 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Hirofumi Matsumoto, Akiko Ishii, Norihiro Nakada, (unknown), (unknown), (unknown), Hisamitsu Zaha	1
5	Spiradenoma of the breast: a rare diagnostic pitfall in the evaluation of solid-basaloid breast lesions with a dual cell population 2020 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Hirofumi Matsumoto, Reika Takamatsu, (unknown), (unknown), Hisamitsu Zaha, Akiko Ishii, Norihiro Nakada, Hiroshi Nishihara, Puay Hoon Tan, Naoki Yoshimi	2
6	Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors 2020 ·Cancer Letters ·Yasutaka Sakurai, Masaaki Ichinoe, Kazuki Yoshida, (unknown), Shoji Saito, Masashi Satoh, Norihiro Nakada, (unknown), Atsuko Umezawa, (unknown), Shi‐Xu Jiang, Masatoshi Ichihara, Masahide Takahashi, Yoshiki Murakumo	20
7	Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis‐associated colorectal cancer 2020 ·Pathology International ·Norihiro Nakada, Tetuo Mikami, Kayo Horie, Ryo Nagashio, Yasutaka Sakurai, (unknown), Tsutomu Yoshida, Miwa Sada, Kiyonori Kobayashi, Yuichi Sato, Isao Okayasu, Yoshiki Murakumo	16
8	Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer 2019 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Hirofumi Matsumoto, Reika Takamatsu, Kentaro Tamaki, (unknown), (unknown), Yoshihiko Kamada, Nobumitsu Tamaki, (unknown), (unknown), Norihiro Nakada, Hisamitsu Zaha, Naoki Yoshimi	10
9	Granuloma With an Underlying Lymphoma: A Diagnostic Challenge and a Wider Histologic Spectrum Including Adult T-Cell Leukemia/Lymphoma 2019 ·Applied immunohistochemistry & molecular morphology ·Chih‐Ying Wu, Ren‐Ching Wang, (unknown), Wei‐Yu Chen, (unknown), Ming-Chih Chang, Yu‐Hung Wu, Norihiro Nakada, Kennosuke Karube, Shih‐Sung Chuang	14
10	Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report 2018 ·Respiratory Medicine Case Reports ·(unknown), Sakiko Otani, Norihiro Nakada, Jiichiro Sasaki, Hideo Saka, Noriyuki Masuda	0
11	CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma 2016 ·International Journal of Hematology ·(unknown), Masaaki Ichinoe, (unknown), Yasutaka Sakurai, Norihiro Nakada, Nobuyuki Yanagisawa, Shi‐Xu Jiang, (unknown), Atsuko Umezawa, Kôji Miyazaki, Masaaki Higashihara, Yoshiki Murakumo	22
12	L-type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling 2015 ·Pathology - Research and Practice ·Masaaki Ichinoe, Nobuyuki Yanagisawa, Tetuo Mikami, Kiyomi Hana, Norihiro Nakada, Hitoshi Endou, Isao Okayasu, Yoshiki Murakumo	19
13	L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management 2015 ·Cancer Biomarkers ·Nobuyuki Yanagisawa, Takefumi Satoh, Kiyomi Hana, Masaaki Ichinoe, Norihiro Nakada, Hitoshi Endou, Isao Okayasu, Yoshiki Murakumo	19
14	Unique and selective expression of L-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein. 2014 ·PubMed ·Norihiro Nakada, Tetuo Mikami, Kiyomi Hana, Masaaki Ichinoe, Nobuyuki Yanagisawa, Tsutomu Yoshida, Hitoshi Endou, Isao Okayasu	34
15	High expression of L‐type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas 2014 ·Cancer Medicine ·Nobuyuki Yanagisawa, Kiyomi Hana, Norihiro Nakada, Masaaki Ichinoe, Wasaburo Koizumi, Hitoshi Endou, Isao Okayasu, Yoshiki Murakumo	32
16	Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression 2013 ·Human Pathology ·Tetuo Mikami, (unknown), (unknown), Kiyomi Hana, Norihiro Nakada, Masaaki Ichinoe, Yoshiki Murakumo, Isao Okayasu	10
17	High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas 2012 ·Journal of Clinical Pathology ·Nobuyuki Yanagisawa, Masaaki Ichinoe, Tetuo Mikami, Norihiro Nakada, Kiyomi Hana, Wasaburo Koizumi, Hitoshi Endou, Isao Okayasu	64
18	Tumor budding, myofibroblast proliferation, and fibrosis in obstructing colon carcinoma: The roles of Hsp47 and basic fibroblast growth factor 2012 ·Pathology - Research and Practice ·(unknown), Tetuo Mikami, Takatoshi Nakamura, Tomoko Tsuruta, Norihiro Nakada, Nobuyuki Yanagisawa, Shi‐Xu Jiang, Isao Okayasu	15
19	Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma 2011 ·Diagnostic Pathology ·Tetuo Mikami, Tsutomu Yoshida, (unknown), (unknown), (unknown), Norihiro Nakada, Isao Okayasu	15
20	High expression of L‐type amino‐acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non‐cancerous lesions 2011 ·Pathology International ·Masaaki Ichinoe, Tetuo Mikami, Tsutomu Yoshida, (unknown), Tomoko Tsuruta, Norihiro Nakada, Naohiko Anzai, Yoshiyuki Suzuki, Hitoshi Endou, Isao Okayasu	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact